Showing 2411 - 2420 of 3137 for "Pharmaceuticals and life sciences" with applied filters
22 September 2022 by
asialaw's Deal of the Month for September 2022 is...
22 September 2022 by
asialaw's Lawyer of the Month for September 2022 is...
20 September 2022 by
In India, for intellectual property (IP) disputes, the statutes and courts have always been more focused on compensatory damages, i.e., compensating the aggrieved party to help them restore their position. This approach has led to a lack in the IP regime as it did not effectively achieve the twin objective of compensation and deterrence.
06 September 2022 by
The ever-growing industry of Peer-to-Peer Lending (“P2P Lending”) has driven the Financial Services Authority (Otoritas Jasa Keuangan – “OJK”) to issue OJK Regulation No. 10/POJK.05/2022 on Technology-Based Collective Financing Services, which came into force on 4 July 2022. The regulation provides more detailed and extensive provisions to cater with the rapid development of the industry. This advisory serves as a brief introduction to the regulation, in order to gauge the new regulatory framework for P2P Lending and how it differs from its predecessor, including the transition period for existing P2P Lending Providers to comply with the new requirements under this regulation.
05 September 2022 by
Corporations often turn to arbitration to manage risks of being hauled into unfamiliar national courts and unpredictable laws. An often overlooked consequence of choosing arbitration is that available discovery may be limited, as a trade-off to efficiency and cost-saving. But in many civil law jurisdictions such as South Korea, discovery practice may be more limited than arbitral proceedings seated in common law jurisdictions or governed by their laws. In this regard, discovery in U.S. litigation stands out unparalleled.
01 September 2022 by
Helmsman LLC is pleased to announce the firm’s official transition into a multi-disciplinary law firm servicing clients and partners throughout the Asia Pacific, Greater China and further afield.
31 August 2022 by
SSEK Legal Consultants, acting as Indonesian counsel, has assisted London-based media company Moonbug Entertainment on the acquisition of Singapore-based media company and production studio One Animation.
30 August 2022 by
As known by many in the Intellectual Property industry the WIPO was working on the tool named “WIPO sequence” since 2020. Its first stable release was launched on April 7, 2020, followed by two consecutive releases till the final version i.e. WIPO Standard ST.26 went live on July 01, 2022. As soon as this tool was launched all the PCT countries including India recognized its importance. Consequently, the Indian Patent Office on 17th June 2022 issued a public notice informing all the stakeholders that all Sequence Listings that are part of an international application filed on and after 1st July 2022 under the Patent Cooperation Treaty must be compliant with WIPO Standard ST.26.
26 August 2022 by
Kim & Chang acted as counsel for LG Energy Solution in its IPO to list its shares on the Korea Exchange's KOSPI Market. LG Energy Solution is one of the global leaders in the rechargeable battery industry with production and R&D networks around the world.
23 August 2022 by
In normal circumstances a patentee/patent applicant resists and rather abhor curtailing or pruning of the claims of their invention. The recourse to the use instrument of disclaimer is adopted by the patent applicant/patent in extreme cases where the objection to clarify the exact scope of the invention is called into question, when they are faced with the refusal /invalidity of their patent claims.
